Patents Assigned to Atlantic Pharmaceuticals, Inc.
-
Patent number: 8647669Abstract: A dosage form from which a burst release of a drug contained within a tampered dosage form is reduced or retarded by the presence in or on the dosage form of a TPTA (Tamper Prone Therapeutic Agent) trap. If the dosage form has not been tampered with, the TPTA trap does not significantly interfere with the rate of release of the drug from the dosage form. However, if the dosage form has been physically tampered with, the TPTA trap reduces or retards burst release of the drug from the dosage form.Type: GrantFiled: April 11, 2013Date of Patent: February 11, 2014Assignee: Atlantic Pharmaceuticals, Inc.Inventor: Krishna Shukla
-
Publication number: 20130224265Abstract: A dosage form from which a burst release of a drug contained within a tampered dosage form is reduced or retarded by the presence in or on the dosage form of a TPTA (Tamper Prone Therapeutic Agent) trap. If the dosage form has not been tampered with, the TPTA trap does not significantly interfere with the rate of release of the drug from the dosage form. However, if the dosage form has been physically tampered with, the TPTA trap reduces or retards burst release of the drug from the dosage form.Type: ApplicationFiled: April 11, 2013Publication date: August 29, 2013Applicant: Atlantic Pharmaceuticals, Inc.Inventors: Anthony Edward Soscia, Yingxu Peng, Yichun Sun, James R. Johnson
-
Patent number: 8507001Abstract: A dosage form from which a burst release of a drug contained within a tampered dosage form is reduced or retarded by the presence in or on the dosage form of a TPTA (Tamper Prone Therapeutic Agent) trap. If the dosage form has not been tampered with, the TPTA trap does not significantly interfere with the rate of release of the drug from the dosage form. However, if the dosage form has been physically tampered with, the TPTA trap reduces or retards burst release of the drug from the dosage form.Type: GrantFiled: December 3, 2012Date of Patent: August 13, 2013Assignee: Atlantic Pharmaceuticals, Inc.Inventor: Anthony Edward Soscia
-
Publication number: 20130095148Abstract: A dosage form from which a burst release of a drug contained within a tampered dosage form is reduced or retarded by the presence in or on the dosage form of a TPTA (Tamper Prone Therapeutic Agent) trap. If the dosage form has not been tampered with, the TPTA trap does not significantly interfere with the rate of release of the drug from the dosage form. However, if the dosage form has been physically tampered with, the TPTA trap reduces or retards burst release of the drug from the dosage form.Type: ApplicationFiled: December 3, 2012Publication date: April 18, 2013Applicant: Atlantic Pharmaceuticals, Inc.Inventors: Anthony Edward Soscia, Yingxu Peng, Yichun Sun, James R. Johnson, Atul J. Shukla
-
Patent number: 8349362Abstract: A dosage form from which a burst release of a drug contained within a tampered dosage form is reduced or retarded by the presence in or on the dosage form of a TPTA (Tamper Prone Therapeutic Agent) trap. If the dosage form has not been tampered with, the TPTA trap does not significantly interfere with the rate of release of the drug from the dosage form. However, if the dosage form has been physically tampered with, the TPTA trap reduces or retards burst release of the drug from the dosage form.Type: GrantFiled: April 24, 2012Date of Patent: January 8, 2013Assignee: Atlantic Pharmaceuticals, Inc.Inventors: Anthony Edward Soscia, Yingxu Peng, Yichun Sun, James R. Johnson, Atul J. Shukla
-
Publication number: 20120207797Abstract: A dosage form from which a burst release of a drug contained within a tampered dosage form is reduced or retarded by the presence in or on the dosage form of a TPTA (Tamper Prone Therapeutic Agent) trap. If the dosage form has not been tampered with, the TPTA trap does not significantly interfere with the rate of release of the drug from the dosage form. However, if the dosage form has been physically tampered with, the TPTA trap reduces or retards burst release of the drug from the dosage form.Type: ApplicationFiled: April 24, 2012Publication date: August 16, 2012Applicant: Atlantic Pharmaceuticals, Inc.Inventors: Anthony Edward Soscia, Yingxu Peng, Yichun Sun, James R. Johnson, Atul J. Shukla
-
Patent number: 8187636Abstract: A dosage form from which a burst release of a drug contained within a tampered dosage form is reduced or retarded by the presence in or on the dosage form of a TPTA (Tamper Prone Therapeutic Agent) trap. If the dosage form has not been tampered with, the TPTA trap does not significantly interfere with the rate of release of the drug from the dosage form. However, if the dosage form has been physically tampered with, the TPTA trap reduces or retards burst release of the drug from the dosage form.Type: GrantFiled: September 25, 2006Date of Patent: May 29, 2012Assignee: Atlantic Pharmaceuticals, Inc.Inventors: Anthony Edward Soscia, Yingxu Peng, Yichun Sun, James R. Johnson, Atul J. Shukla
-
Patent number: 6162829Abstract: The present invention relates to non-psychoactive derivatives of tetrahydro-cannabinol, which exhibit anti-inflammatory, analgesic and leukocyte antiadhesion activities. The invention includes novel derivatives of (3R,4R)-.DELTA..sup.8 -tetrahydrocannabinol-11-oic acids [hereinafter referred to as (3R,4R)-.DELTA..sup.8 -THC-11-oic acid], as well as pharmaceutical compositions containing the (3R,4R)-.DELTA..sup.8 -THC-11-oic acid derivatives. The invention further covers methods of administering the novel derivatives and pharmaceutical compositions as therapeutic agents in the treatment of pain and tissue inflammation. Non-psychoactive derivatives of .DELTA..sup.8 -THC-11-oic acid are described which have analgesic and anti-inflammatory properties.Type: GrantFiled: October 17, 1997Date of Patent: December 19, 2000Assignee: Atlantic Pharmaceuticals, Inc.Inventor: Sumner H. Burstein